Silence Therapeutics (SLN) Short Interest Ratio & Short Volume → Urgent: Protect Your Investments from a Chinese Invasion (From Behind the Markets) (Ad) Free SLN Stock Alerts $21.82 0.00 (0.00%) (As of 02:46 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Silence Therapeutics Short Interest DataCurrent Short Volume92,700 sharesPrevious Short Volume46,200 sharesChange Vs. Previous Month+100.65%Dollar Volume Sold Short$2.12 millionShort Interest Ratio / Days to Cover0.4Last Record DateMarch 15, 2024Outstanding Shares29,928,000 sharesPercentage of Shares Shorted0.31%Today's Trading Volume70,170 sharesAverage Trading Volume258,604 sharesToday's Volume Vs. Average27% Short Selling Silence Therapeutics ? Sign up to receive the latest short interest report for Silence Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSLN Short Interest Over TimeSLN Days to Cover Over TimeSLN Percentage of Float Shorted Over Time Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> Silence Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202492,700 shares $2.12 million +100.7%N/A0.4 $22.84 2/29/202446,200 shares $1.18 million +31.6%N/A0.2 $25.47 2/15/202435,100 shares $768,339.00 -76.9%N/A0.2 $21.89 1/31/2024152,200 shares $3.43 million +6.7%N/A0.9 $22.51 1/15/2024142,700 shares $2.53 million +7.9%N/A1.3 $17.70 12/31/2023132,200 shares $2.30 million +1.0%N/A1.7 $17.37 Get the Latest News and Ratings for SLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/15/2023130,900 shares $2.10 million -7.8%N/A2.3 $16.03 11/30/2023141,900 shares $1.83 million +1.0%N/A3.1 $12.87 11/15/2023140,500 shares $1.32 million +4.1%N/A2 $9.39 10/31/2023135,000 shares $904,500.00 -3.6%N/A2.2 $6.70 10/15/2023140,000 shares $1.09 million +3.1%N/A2.1 $7.76 9/30/2023135,800 shares $1.33 million +5.0%N/A2.1 $9.82 9/15/2023129,400 shares $1.29 million +7.9%N/A1.9 $9.95 8/31/2023119,900 shares $1.07 million -4.2%N/A1.3 $8.90 8/15/2023125,100 shares $800,640.00 +24.0%N/A2.2 $6.40 7/31/2023100,900 shares $601,364.00 +41.3%0.4%1.5 $5.96 7/15/202371,400 shares $414,120.00 +349.1%0.3%1 $5.80 6/30/202315,900 shares $87,450.00 +52.9%0.1%0.2 $5.50 6/15/202310,400 shares $63,752.00 +7.2%0.0%0.1 $6.13 5/31/20239,700 shares $51,507.00 -56.7%0.0%0.1 $5.31 5/15/202322,400 shares $131,488.00 -36.7%0.1%0.3 $5.87 4/30/202335,400 shares $237,180.00 +91.4%0.1%0.6 $6.70 4/15/202318,500 shares $114,700.00 +30.3%0.1%0.3 $6.20 3/31/202314,200 shares $88,040.00 +11.8%0.1%0.4 $6.20 3/15/202312,700 shares $116,332.00 -12.4%0.0%0.3 $9.16 2/28/202314,500 shares $169,940.00 -17.1%0.1%0.3 $11.72 2/15/202317,500 shares $226,275.00 -22.2%0.1%0.5 $12.93 1/31/202322,500 shares $292,500.00 -2.6%0.1%0.7 $13.00 1/15/202323,100 shares $328,944.00 -24.3%0.1%0.7 $14.24 12/30/202230,500 shares $465,125.00 -23.9%0.1%0.9 $15.25 12/15/202240,100 shares $571,425.00 +28.9%0.1%1 $14.25 11/30/202231,100 shares $487,648.00 +16.5%0.1%0.7 $15.68 11/15/202226,700 shares $368,193.00 +24.2%0.1%0.6 $13.79 10/31/202221,500 shares $247,680.00 -30.7%0.1%0.4 $11.52 10/15/202231,000 shares $331,700.00 -8.3%0.1%0.5 $10.70 9/30/202233,800 shares $339,014.00 +39.7%0.1%0.6 $10.03 9/15/202224,200 shares $310,728.00 +50.3%0.1%0.4 $12.84 8/31/202216,100 shares $162,771.00 -13.9%0.1%0.3 $10.11 8/15/202218,700 shares $182,512.00 +24.7%0.1%0.4 $9.76 7/31/202215,000 shares $153,000.00 -20.6%0.1%0.4 $10.20Urgent: Protect Your Investments from a Chinese Invasion (Ad)An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> SLN Short Interest - Frequently Asked Questions What is Silence Therapeutics' current short interest? Short interest is the volume of Silence Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 92,700 shares of SLN short. Learn More on Silence Therapeutics' current short interest. Is Silence Therapeutics' short interest increasing or decreasing? Silence Therapeutics saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 92,700 shares, an increase of 100.6% from the previous total of 46,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Silence Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Silence Therapeutics: Acelyrin, Inc. (13.95%), Mineralys Therapeutics, Inc. (5.75%), Neurogene Inc. (3.42%), CureVac (5.31%), Calliditas Therapeutics AB (publ) (0.02%), Nuvation Bio Inc. (1.97%), Nurix Therapeutics, Inc. (13.11%), Savara Inc (5.09%), Olema Pharmaceuticals, Inc. (9.05%), Phathom Pharmaceuticals, Inc. (40.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Silence Therapeutics stock? Short selling SLN is an investing strategy that aims to generate trading profit from Silence Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Silence Therapeutics? A short squeeze for Silence Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLN, which in turn drives the price of the stock up even further. How often is Silence Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLN, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Acelyrin Short Interest Mineralys Therapeutics Short Interest Neurogene Short Interest CureVac Short Interest Calliditas Therapeutics AB (publ) Short Interest Nuvation Bio Short Interest Nurix Therapeutics Short Interest Savara Short Interest Olema Pharmaceuticals Short Interest Phathom Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLN) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeAI to Meet the Same Fate as EVs? Porter & CompanyGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy